Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Cash-strapped Africa overwhelmed by COVID vaccine challenge

WorldApr 21, 2021 02:31AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
2/2 © Reuters. FILE PHOTO: Ghana launches COVID-19 vaccination campaign 2/2

By Edward McAllister

DAKAR (Reuters) - When Ghana received 50,000 COVID-19 vaccine doses from India last month, it hit a frustrating roadblock: it had not trained enough staff to distribute them.

The country was still rolling out shots received in late February from the global vaccine-sharing scheme COVAX, and didn't have the capacity to expand that operation, according to the head of Ghana's immunisation programme.

Rather than going straight into the arms of health workers, the additional doses were put in cold storage in the capital Accra, Kwame Amponsa-Achiano told Reuters, adding that his team had received two days' notice about the shipment.

"We were in the middle of the first campaign," Amponsa-Achiano said. "How do you plan for 50,000 when you already are doing another campaign?"

The problems faced by Ghana, one of sub-Saharan Africa's more economically developed nations, illustrate how a continent with experience in battling deadly infectious diseases has found itself ill-prepared to inoculate people against this pandemic.

Many African countries, already facing a shortage of affordable vaccines, are being stunned by the unprecedented scale of the distribution challenge when doses do arrive.

Authorities do not have enough equipment like masks and cotton wool because of funding shortfalls that could total billions of dollars, according to more than a dozen health experts and some internal government documents seen by Reuters.

They also lack sufficient personnel and training to distribute vaccines at short notice.

While Africa has thus far been relatively unscathed by COVID-19, some experts fear stuttering rollouts could draw out the outbreak in the region, potentially leading to more deaths and economically damaging restrictions in a continent that is already the poorest in the world.

Benjamin Schreiber, COVAX coordinator at the U.N. children's agency UNICEF, said logistical problems could mount in the coming weeks and months as countries tried to get vaccines to their general populations.

"As we start rolling out bigger quantities, we are going to start seeing more issues," Schreiber said.

"The gaps in the healthcare systems will be the gaps that hinder the rollouts," he added. "My worry is that we miss complete communities."


Ghana, where the novel coronavirus has infected more than 91,000 and killed over 750, is considered one of the better-prepared countries in Africa to carry out a mass vaccination drive because of its political stability and economic development.

The government aims to initially inoculate 17.6 million people - about half of its population - at a cost of $51.7 million, according to a national plan seen by Reuters.

It hopes to cover $7.9 million of that money with a World Bank loan but is short of $43.8 million, described as a "funding gap" in the internal government document.

Immunisation chief Amponsa-Achiano said he was not aware that the situation had changed since the plan was formulated in February.

The Ghanaian finance and health ministries did not respond to requests for comment.

Ghana was the first country in the world to receive a shipment from COVAX, taking delivery of 600,000 doses of the AstraZeneca/Oxford University vaccine, manufactured in India, on Feb. 24.

It started its vaccine drive on March 1, and had vaccinated 599,000 people by April 7.

While that vaccination rate is better than many of its African peers - Ivory Coast vaccinated just over 53,000 people between March 1 and April 6 - it is far behind the fastest countries globally. Britain, for example, administered doses to about 2 million people in roughly the first month of its drive.


The Ghanaian national plan shows how even relatively prosperous African nations lack vital equipment.

Money is needed across the board, including $1.5 million for 11 walk-in cold rooms and over 650 fridges to keep vaccines at between 2 and 8 degrees Celsius.

About $25 million is needed for supplies and waste management, including 33,600 boxes of face masks, 240,000 bottles of hand sanitizer, and nearly 55,000 rolls of cotton wool, the plan says. About $21 million is needed to train over 171,000 health workers and volunteers.

To add to Ghana's challenge, its next COVAX shipments, expected in April and May, have been delayed until June, because India suspended major exports of vaccines manufactured there.

In its 2021 budget, outlined in mid-March, the Ghanaian government allotted 929,296,610 cedis ($160 million) for vaccine acquisition and deployment.

Amponsa-Achiano said, though, it was not clear how much would go towards distribution, or when the funds would materialise.

It is a common problem in Africa, UNICEF's Schreiber said.

"The question is at what point will this funding hit the ground? Will it be in time?"


Some African authorities are familiar with deadly contagions. Since 2018, Congo has contained four Ebola outbreaks with a vaccine which must be stored at between -60 and -80 degrees Celsius.

But the scale of the COVID-19 vaccination drive is new.

COVAX - the donor scheme co-led by the World Health Organisation (WHO) - has delivered over 18 million doses to 41 African countries, according to Reuters data.

That's the first wave in a drive expected to deliver 600 million doses to Africa this year, enough to vaccinate 20% of their populations. Russia, China and India have also donated some of their vaccines.

Funding is only one issue delaying vaccine rollouts.

Another is patchy record-keeping in many public health systems, which experts say make it difficult to identify people who should be prioritised because of age or co-morbidities.

Demand for shots is also weak in some countries due to mistrust of health authorities, lack of education about the vaccines and worries about potential side effects.

Spotty electricity and poor transport links in some places add to the challenge, while medical teams will have to negotiate safe passage across parts of Democratic Republic of Congo, Mali, Somalia and other places where insurgencies rage.


John Nkengasong, who heads the Africa Centres for Disease Control and Prevention, says it could take until the end of 2022 to vaccinate 60% of the continent's 1.3 billion people.

Take the task facing Mali, an impoverished country fighting an Islamist insurgency. It needs $14.7 million to deploy vaccines, including for gasoline, vaccine storage and training, according to an internal government vaccination plan seen by Reuters.

The government will need funding support from the WHO, UNICEF, the GAVI vaccine alliance and the World Bank, the plan says. Those organisations are all looking to provide funding to African nations facing shortfalls.

South Sudan, still racked by violence after a civil war ended in 2018, has seen COVID-19 infect at least 10,300 people and kill more than 100.

It began distributing 132,000 vaccine doses from COVAX on April 7. However, authorities won't start administering shots outside the capital Juba and its surrounding county until May at the earliest, said Kawa Tong, a member of a COVID-19 steering committee that advises the government.

"The key reason is the lack of funds for a rollout outside Juba. The transport of vaccines, training of health workers, community outreach - all these are tied to funding," Tong told Reuters.

Adding to the difficulties, by May the rainy season will be well underway, cutting off transport links to large parts of the country, she said. The vast majority of the 11 million-strong population live outside Juba county.

    Atem Riek Anyom, director general for primary healthcare at South Sudan's health ministry, said the government had requested World Bank funding, adding that vaccines would soon be deployed across the country.

"There's no challenge in regards to the vaccine rollout," he added.  

The World Bank, which has a $12 billion fund to help developing countries around the world buy and distribute vaccines, said it was reviewing requests from Mali and South Sudan.

The bank said it has approved $2 billion to 17 countries, including seven in Africa: Ethiopia, Cape Verde, Ivory Coast, Eswatini, Tunisia, Rwanda and Gambia.

Cash-strapped Africa overwhelmed by COVID vaccine challenge

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email